Epigenetics in human disease and prospects for epigenetic therapy
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Epigenetic mechanisms, which involve DNA and histone modifications, result in the heritable silencing of genes without a change in their coding sequence. The study of human disease has focused on genetic mechanisms, but disruption of the balance of epigenetic networks can cause several major pathologies, including cancer, syndromes involving chromosomal instabilities, and mental retardation. The development of new diagnostic tools might reveal other diseases that are caused by epigenetic alterations. Great potential lies in the development of 'epigenetic therapies'--several inhibitors of enzymes controlling epigenetic modifications, specifically DNA methyltransferases and histone deacetylases, have shown promising anti-tumorigenic effects for some malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are three main types of epigenetic modifications: DNA methylation, histone modifications, and various RNA-mediated processes (39, 40).”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [39]
In the citing paper
“and represents a prominent candidate to be a marker of ROS-induced mutagenesis and tumorigenesis41.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [41]
In the citing paper
“Activation and/or aberrant expression of a gene can contribute to the development of endometriosis, cancers, or other abnormalities.22”
From Altered genome-wide methylation in endometriosis (2014) · cites this paper as [22]
In the citing paper
“Many reports have demonstrated that epigenetic alterations play important roles in driving cancer initiation and progression [123, 124].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [123]
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“On a more global level, the ICF (immunodeficiency, centromeric region instability and facial anomalies) syndrome is caused by mutations in the DNMT3b gene, which is an essential enzyme required for the establishment of DNA methylation pattern”
BackgroundThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationRett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Self-citationThe history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
Regulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi
Volpe, T. A., Kidner, C., Hall, I. M., Teng, G., Grewal, S. I. S., & Martienssen, R. A. (2002) · Science · doi:10.1126/science.1074973 · Cited by 2,055
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Holliday, R., & Pugh, J. E. (1975) · Science · doi:10.1126/science.187.4173.226 · Cited by 1,972
Cited by
Items 501–600 of 1,013
Leung, W. K., To, K., Chu, E. S., Chan, M. W. Y., Bai, A. H. C., Ng, E. K. W., Chan, F. K. L., & Sung, J. J. �. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602636 · Cited by 98
Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy
Gowher, H., & Jeltsch, A. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.11.1308 · Cited by 106
Evens, A. M., Balasubramanian, S., Vose, J. M., Harb, W., Gordon, L. I., Langdon, R., Sprague, J., Sirisawad, M., Mani, C., Yue, J., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0624 · Cited by 96
Bhalla, S., Balasubramanian, S., David, K. A., Sirisawad, M., Buggy, J. J., Mauro, L. A., Prachand, S., Miller, R. A., Gordon, L. I., & Evens, A. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2365 · Cited by 107
Ruptured abdominal aortic aneurysm—epidemiology, predisposing factors, and biology
Schmitz‐Rixen, T., Keese, M. A., Hakimi, M., Peters, A. S., Böckler, D., Nelson, K., & Grundmann, R. T. (2016) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-016-1401-8 · Cited by 106
Epigenetics and depression: current challenges and new therapeutic options
Schroeder, M., Krebs, M. O., Bleich, S., & Frieling, H. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32833d16c1 · Cited by 90
Druz, A., Betenbaugh, M., & Shiloach, J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks452 · Cited by 95
Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis
Vogiatzi, P., Vindigni, C., Roviello, F., Renieri, A., & Giordano, A. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20982 · Cited by 102
Morahan, J. M., Yu, B., Trent, R. J., & Pamphlett, R. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960802635397 · Cited by 91
The role of epigenetic alterations in pancreatic cancer
Sato, N., & Goggins, M. (2006) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-005-1057-1 · Cited by 103
Kim, M., Jang, H.-R., Kim, J., Noh, S.-M., Song, K.-S., Cho, J.-S., Jeong, H. Y., Norman, J. C., Caswell, P. T., Kang, G. H., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm291 · Cited by 96
Burris, H. H., Braun, J. M., Byun, H.-M., Tarantini, L., Mercado, A., Wright, R. J., Schnaas, L., Baccarelli, A. A., Wright, R. O., & Tellez-Rojo, M. M. (2013) · Epigenomics · doi:10.2217/epi.13.24 · Cited by 94
A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)
Shen, S., & Kozikowski, A. P. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1708901 · Cited by 90
MicroRNA epigenetic alterations in human cancer: One step forward in diagnosis and treatment
Yang, N., Coukos, G., & Zhang, L. (2007) · International Journal of Cancer · doi:10.1002/ijc.23325 · Cited by 101
Gao, W., Gu, Y., Li, Z., Cai, H., Peng, Q., Tu, M., Kondo, Y., Shinjo, K., Zhu, Y., Zhang, J., et al. (2014) · Oncogene · doi:10.1038/onc.2014.101 · Cited by 99
Epigenotypes of Latent Herpesvirus Genomes
Minárovits, J. (2006) · Springer eBooks · doi:10.1007/3-540-31181-5_5 · Cited by 100
Increased Adiposity in Adults Born Preterm and Their Children
Mathai, S., Derraik, J. G. B., Cutfield, W. S., Dalziel, S. R., Harding, J. E., Biggs, J., Jefferies, C., & Hofman, P. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081840 · Cited by 92
3p21.3 tumor suppressor cluster: prospects for translational applications
Ji, L., Minna, J. D., & Roth, J. A. (2005) · Future Oncology · doi:10.1517/14796694.1.1.79 · Cited by 104
Epigenetic regulation in alcoholic liver disease
Mandrekar, P. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i20.2456 · Cited by 99
Sukocheva, O. A., Lukina, E., Friedemann, M., Menschikowski, M., Hagelgans, A., & Aliev, G. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.004 · Cited by 100
der Auwera, I. V., Elst, H., Laere, S. V., Maes, H., Huget, P., van Dam, P. A., Marck, E. A. V., Vermeulen, P. B., & Dirix, L. Y. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605013 · Cited by 94
Chromatin-remodelling mechanisms in cancer
Lafon-Hughes, L., Tomaso, M. V. D., Méndez-Acuña, L., & Martínez‐López, W. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.01.008 · Cited by 106
Ben-Kasus, T., Ben‐Zvi, Z., Márquez, V. E., Kelley, J. A., & Agbaria, R. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.010 · Cited by 94
Wang, Y., Wang, X., Li, R., Yang, Z., Wang, Y., Gong, X., & Wang, X. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12059 · Cited by 100
Xu, Y., Ohms, S., Li, Z., Wang, Q., Gong, G., Hu, Y., Mao, Z., Shannon, M. F., & Fan, J. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082062 · Cited by 98
Li, L., Yu, X., Yang, Y., Zhang, C., Guo, L., & Lu, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24513 · Cited by 94
A Review on Epigenetic Effect of Heavy Metal Carcinogens on Human Health
Mishra, S., Dwivedi, S. P., & Singh, R. B. (2010) · The Open Nutraceuticals Journal · doi:10.2174/1876396001003010188 · Cited by 118
Veeck, J., Noetzel, E., Bektas, N., Jost, E., Hartmann, A., Knüchel, R., & Dahl, E. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-83 · Cited by 106
Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer
Huqun, Ishikawa, R., Zhang, J., Miyazawa, H., Goto, Y., Shimizu, Y., Hagiwara, K., & Koyama, N. (2011) · Cancer · doi:10.1002/cncr.26441 · Cited by 98
Zhang, K., Wang, J., Yang, L., Yuan, Y., Tong, T. R. S.-W., Wu, J., Yun, X., Bonner, M., Pangeni, R. P., Liu, Z., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0896-8 · Cited by 102
Jing, X., Cao, X., Wang, L., Lan, T., Li, Y., & Xie, G. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.02.035 · Cited by 93
Analysis of tissue-specific differentially methylated regions (TDMs) in humans
Kitamura, E., Igarashi, J., Morohashi, A., Hida, N., Oinuma, T., Nemoto, N., Song, F., Ghosh, S., Held, W. A., Yoshida, C., et al. (2007) · Genomics · doi:10.1016/j.ygeno.2006.11.006 · Cited by 123
Brueckner, B., Rius, M., Markelova, M. R., Fichtner, I., Hals, P., Sandvold, M. L., & Lyko, F. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1202 · Cited by 92
Small Molecule Inhibitors of Histone Acetyltransferases as Epigenetic Tools and Drug Candidates
Furdas, S. D., Kannan, S., Sippl, W., & Jung, M. (2011) · Archiv der Pharmazie · doi:10.1002/ardp.201100209 · Cited by 101
Long, X., He, Y., Huang, C. Z., & Li, J. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2373 · Cited by 95
Pavagadhi, S., & Balasubramanian, R. (2013) · Aquatic Toxicology · doi:10.1016/j.aquatox.2013.07.010 · Cited by 104
Bull, C., & Fenech, M. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s0029665108006988 · Cited by 91
Saito, Y., Saito, H., Liang, G., & Friedman, J. M. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-013-8401-z · Cited by 94
Self-citationKlug, M., Heinz, S., Gebhard, C., Schwarzfischer, L., Krause, S. W., Andreesen, R., & Rehli, M. (2010) · Genome Biology · doi:10.1186/gb-2010-11-6-r63 · Cited by 90
Weber, B., Kimhi, S., Howard, G., Eden, A., & Lyko, F. (2010) · Oncogene · doi:10.1038/onc.2010.227 · Cited by 99
Gao, Y., & Tollefsbol, T. O. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082204 · Cited by 90
“These epigenetic changes have been known to play important roles in the development of different types of cancer, including breast cancers [3].”
BackgroundOverview of Cardiac Arrhythmias and Treatment Strategies
Kingma, J. G., Simard, C., & Drolet, B. (2023) · Pharmaceuticals · doi:10.3390/ph16060844 · Cited by 108
Epigenetic histone modification regulates developmental lead exposure induced hyperactivity in rats
Luo, M., Xu, Y., Cai, R., Tang, Y., Ge, M.-M., Liu, Z., Xu, L., Hu, F., Ruan, D., & Wang, H.-L. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.11.025 · Cited by 92
PRAME expression and promoter hypomethylation in epithelial ovarian cancer
Zhang, W., Barger, C. J., Eng, K. H., Klinkebiel, D. L., Link, P. A., Omilian, A. R., Bshara, W., Odunsi, K. O., & Karpf, A. R. (2016) · Oncotarget · doi:10.18632/oncotarget.9977 · Cited by 91
Analyzing the cancer methylome through targeted bisulfite sequencing
Lee, E.-J., Luo, J., Wilson, J. M., & Shi, H. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.040 · Cited by 101
Nasu, K., Kawano, Y., Tsukamoto, Y., Takano, M., Takai, N., Li, H., Furukawa, Y., Abe, W., Moriyama, M., & Narahara, H. (2011) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2011.01663.x · Cited by 88
Epigenetic changes in virus-associated human cancers
Hsin Pai, L. I., Leu, Y. W., & Chang, Y. (2005) · Cell Research · doi:10.1038/sj.cr.7290295 · Cited by 97
Epigenetics of Cancer Progression
Vucic, E. A., Brown, C. J., & Lam, W. L. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.2.215 · Cited by 99
Raaphorst, F. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi111 · Cited by 95
Fenoglio, C., Scarpini, E. A., Serpente, M., & Galimberti, D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170702 · Cited by 101
Shann, Y., Cheng, C., Chiao, C.-H., Chen, D.-T., Li, P.-H., & Hsu, M. (2008) · Genome Research · doi:10.1101/gr.070961.107 · Cited by 99
Words, K., Genetics, H. M., Ismail, O., Varshney, D., Lymperi, S., Sandi, C., Trabzuni, D., & Pook, M. A. (1996) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)89770-1 · Cited by 89
Molecular damage in cancer: an argument for mTOR-driven aging
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100422 · Cited by 90
Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation
Zahnow, C. A., Topper, M. J., Stone, M. L., Stewart, T. M., Li, H., Baylin, S. B., & Casero, R. A. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.01.007 · Cited by 95
Tumor-Initiating and -Propagating Cells: Cells That We Would to Identify and Control
Tysnes, B. B. (2010) · Neoplasia · doi:10.1593/neo.10290 · Cited by 100
Epigenetic regulation of Th1 and Th2 cell development
Sanders, V. M. (2005) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2005.08.005 · Cited by 94
Šrámková, L., Mužíková, K., Froňková, E., Krejci, O., Sedláček, P., Formánková, R., Mejstříková, E., Starý, J., & Trka, J. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20794 · Cited by 88
Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia
Fazi, F., Zardo, G., Gelmetti, V., Travaglini, L., Ciolfi, A., Di Croce, L., Rosa, A., Bozzoni, I., Grignani, F., Lo-Coco, F., et al. (2007) · Blood · doi:10.1182/blood-2006-09-045781 · Cited by 88
Saw, G., Krishna, K., Gupta, N., Soong, T. W., Mallilankaraman, K., Sajikumar, S., & Dheen, S. T. (2020) · Glia · doi:10.1002/glia.23748 · Cited by 87
Post-translational modifications of EZH2 in cancer
Li, Z., Li, M., Wang, D., Hou, P., Chen, X., Chu, S., Chai, D., Zheng, J., & Bai, J. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00505-0 · Cited by 92
Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator
Li, F., Qasim, S., Li, D., & Dou, Q. P. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.018 · Cited by 97
Manning, J., Indrova, M., Lubyova, B., Pribylova, H., Bieblova, J., Hejnar, J., Simova, J., Jandlova, T., Bubenik, J., & Reinis, M. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02689.x · Cited by 88
Wang, W. T., Hüper, G., Guo, Y., Murphy, S. K., Olson, J. A., & Marks, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208464 · Cited by 94
Clonal and non-clonal chromosome aberrations and genome variation and aberration
Heng, H. H., Liu, G., Bremer, S. W., Ye, K. J., Stevens, J. B., & Ye, C. J. (2006) · Genome · doi:10.1139/g06-023 · Cited by 92
Epigenetic biomarkers in prostate cancer: Current and future uses
Chiam, K., Ricciardelli, C., & Bianco‐Miotto, T. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.02.011 · Cited by 101
Thamotharan, M., Garg, M., Oak, S., Rogers, L. M., Pan, G., Sangiorgi, F., Lee, P. W. N., & Devaskar, S. U. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00462.2006 · Cited by 85
Verma, M., Maruvada, P., & Srivastava, S. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360490516922 · Cited by 93
Male Obesity: Epigenetic Origin and Effects in Sperm and Offspring
Houfflyn, S., Matthys, C., & Soubry, A. (2017) · Current Molecular Biology Reports · doi:10.1007/s40610-017-0083-5 · Cited by 93
Genetic determinants of pulmonary fibrosis: evolving concepts
Spagnolo, P., Grünewald, J., & du Bois, R. M. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70047-5 · Cited by 89
Zhang, M., Zhai, Y., Zhang, S., Dai, X., & Li, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00782 · Cited by 98
Ishida, T., Hamano, A., Koiwa, T., & Watanabe, T. (2006) · Retrovirology · doi:10.1186/1742-4690-3-69 · Cited by 87
Epigenetics and T-cell immunity
Sawalha, A. H. (2008) · Autoimmunity · doi:10.1080/08916930802024145 · Cited by 88
Epigenomics of cancer – emerging new concepts
Hassler, M. R., & Egger, G. (2012) · Biochimie · doi:10.1016/j.biochi.2012.05.007 · Cited by 95
Self-citationJost, E., do Ó, N., Dahl, E., Maintz, C., Jousten, P., Habets, L., Wilop, S., Herman, J. G., Osieka, R., & Galm, O. (2007) · Leukemia · doi:10.1038/sj.leu.2404513 · Cited by 94
Mothering style and methylation
Sapolsky, R. M. (2004) · Nature Neuroscience · doi:10.1038/nn0804-791 · Cited by 96
EPHB4 and Survival of Colorectal Cancer Patients
Dávalos, V., Dopeso, H., Castaño, J., Wilson, A. J., Vilardell, F., Romero‐Giménez, J., Espín, E., Armengol, M., Capellá, G., Mariadason, J. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4640 · Cited by 85
Developmental programming of the HPA axis and related behaviours: epigenetic mechanisms
Matthews, S. G., & McGowan, P. O. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0057 · Cited by 80
Materials control of the epigenetics underlying cell plasticity
Nemec, S. R., & Kilian, K. A. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-00238-z · Cited by 91
Tanaka, M., Spekker, E., Szabó, Á., Polyák, H., & Vécsei, L. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02513-5 · Cited by 86
Cancer therapy and vaccination
Aly, H. A. A. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.05.014 · Cited by 96
Fujioka, N., Fritz, V. A., Upadhyaya, P., Kassie, F., & Hecht, S. S. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500889 · Cited by 92
Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy
Kgatle, M. M., Kalla, A. A., Islam, M. M., Sathekge, M. M., & Moorad, R. (2016) · Prostate Cancer · doi:10.1155/2016/5653862 · Cited by 96
DNA methylation alterations in Alzheimer’s disease
Yokoyama, A. S., Rutledge, J. C., & Medici, V. (2017) · Environmental Epigenetics · doi:10.1093/eep/dvx008 · Cited by 96
Maternal obesity increases the risk of metabolic disease and impacts renal health in offspring
Glastras, S. J., Chen, H., Pollock, C. A., & Saad, S. (2018) · Bioscience Reports · doi:10.1042/bsr20180050 · Cited by 83
Ezura, Y., Sekiya, I., Koga, H., Muneta, T., & Noda, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24472 · Cited by 88
Liu, Y., Reynolds, L. M., Ding, J., Hou, L., Lohman, K., Young, T., Cui, W., Huang, Z., Grenier, C., Wan, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00517-4 · Cited by 82
Dietary compounds as potential modulators of microRNA expression in psoriasis
Kocić, H., Damiani, G. B., Stamenkovic, B. N., Tirant, M., Jović, A., Tiodorović, D., & Peris, K. (2019) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622319864805 · Cited by 85
DNA Methyltransferase Inhibitors: Catalysts For Antitumour Immune Responses
Dan, H., Zhang, S., Zhou, Y., & Guan, Q. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s217767 · Cited by 86
A comprehensive review on high -fat diet-induced diabetes mellitus: an epigenetic view
Prasad, M., Rajagopal, P., Devarajan, N., Veeraraghavan, V. P., Palanisamy, C. P., Cui, B., Patil, S., & Jayaraman, S. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109037 · Cited by 90
Pathophysiological Mechanisms of Carotid Plaque Vulnerability: Impact on Ischemic Stroke
Pelisek, J., Eckstein, H., & Zernecke, A. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0192-z · Cited by 92
Frequent Inactivation of RAMP2, EFEMP1 and Dutt1 in Lung Cancer by Promoter Hypermethylation
Yue, W., Đačić, S., Sun, Q., Landreneau, R. J., Guo, M., Zhou, W., Siegfried, J. M., Yu, J., & Zhang, L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0015 · Cited by 83
Kodach, L. L., Jacobs, R. J., Heijmans, J., van Noesel, C. J. M., Langers, A. M. J., Verspaget, H. W., Hommes, D. W., Offerhaus, G. J. A., van den Brink, G. R., & Hardwick, J. C. H. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq147 · Cited by 82
Epigenetics and the overhealing wound: the role of DNA methylation in fibrosis
Neary, R., Watson, C. J., & Baugh, J. A. (2015) · Fibrogenesis & Tissue Repair · doi:10.1186/s13069-015-0035-8 · Cited by 90
Epigenetic clues to rheumatoid arthritis
Sánchez‐Pernaute, O., Ospelt, C., Neidhart, M., & Gay, S. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.11.006 · Cited by 83
Altered genome-wide methylation in endometriosis
Naqvi, H., Ilagan, Y., Krikun, G., & Taylor, H. S. (2014) · Reproductive Sciences · doi:10.1177/1933719114532841 · Cited by 82
Genetics and epigenetics of arrhythmia and heart failure
Duygu, B., Poels, E. M., & Martins, P. A. D. C. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00219 · Cited by 91
Epigenetic role of thymoquinone: impact on cellular mechanism and cancer therapeutics
Khan, M. A., Tania, M., & Fu, J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.007 · Cited by 84
Genetics and Epigenetics of Atrial Fibrillation
Lozano-Velasco, E., Franco, D., Aránega, A. E., & Daimi, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165717 · Cited by 88
Animal models of gene–environment interaction in schizophrenia: A dimensional perspective
Ayhan, Y., McFarland, R., & Pletnikov, M. V. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.10.002 · Cited by 81
Yamamoto, N., Nakayama, T., Kajita, M., Miyake, T., Iwamoto, T., Kim, S. J., Sakai, A., Ishihara, H., Tamaki, Y., & Noguchi, S. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1575-2 · Cited by 90
Metadata
- Authors
- Egger, G., Liang, G., Aparicio, A., & Jones, P. A.
- Affiliations
- University of Southern California (US)
- Venue
- Nature
- Published
- 2004-05
- Volume
- 429
- Issue
- 6990
- Pages
- 457-463
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2004172747
- Cited by
- 3,232
- References
- 96
- Citations by year
- 2026: 32 · 2025: 76 · 2024: 100 · 2023: 132 · 2022: 124 · 2021: 175 · 2020: 140 · 2019: 173 · 2018: 185 · 2017: 192 · 2016: 180 · 2015: 208 · 2014: 159 · 2013: 175 · 2012: 153
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Max Kade Foundation
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- epigenetics, epigenetic therapy, DNA methylation, histone modifications, gene silencing, hypomethylating agents, histone deacetylase inhibitors, cancer, chromosomal instability syndromes, intellectual disability
- MeSH terms
- Disease, Genetics, Medical, Humans, Genetic Therapy, DNA Methylation, Gene Silencing, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.